Overview
Jonathan Fromm is a Hematologist in Seattle, Washington. Dr. Fromm is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Non-Hodgkin Lymphoma, and Tissue Biopsy.
His clinical research consists of co-authoring 77 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- PPO
Locations
1959 NE Pacific St, Seattle, WA 98195
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Xinsheng Liao is an Oncologist and a Hematologist in Bellevue, Washington. Dr. Liao is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Inflammatory Breast Cancer, Non-Hodgkin Lymphoma, Paget Disease of the Breast, and Melanoma.
Farnoush Abar is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Abar is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Waldenstrom Macroglobulinemia, Paget Disease of the Breast, Familial Pancreatic Cancer, and Pleuropulmonary Blastoma. Dr. Abar is currently accepting new patients.
The Association Of University Physicians
Paul Martin is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Martin is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Autoimmune Hemolytic Anemia, Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). Dr. Martin is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Classical Hodgkin LymphomaDr. Fromm isDistinguished. Learn about Classical Hodgkin Lymphoma.
- Hodgkin LymphomaDr. Fromm isDistinguished. Learn about Hodgkin Lymphoma.
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)Dr. Fromm isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Anaplastic Large Cell LymphomaDr. Fromm isAdvanced. Learn about Anaplastic Large Cell Lymphoma.
- B-Cell LymphomaDr. Fromm isAdvanced. Learn about B-Cell Lymphoma.
- Follicular LymphomaDr. Fromm isAdvanced. Learn about Follicular Lymphoma.
- Non-Hodgkin LymphomaDr. Fromm isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Experienced
- Acute Monoblastic Leukemia (AmoL)Dr. Fromm isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Adult T-Cell LeukemiaDr. Fromm isExperienced. Learn about Adult T-Cell Leukemia.
- Burkitt LymphomaDr. Fromm isExperienced. Learn about Burkitt Lymphoma.
- Castleman DiseaseDr. Fromm isExperienced. Learn about Castleman Disease.